Creatine Chemical Exchange Saturation Transfer (Cr-CEST) Imaging Can Evaluate Cisplatin-induced Testicular Damage
- PMID: 35545506
- PMCID: PMC10449556
- DOI: 10.2463/mrms.mp.2021-0125
Creatine Chemical Exchange Saturation Transfer (Cr-CEST) Imaging Can Evaluate Cisplatin-induced Testicular Damage
Abstract
Purpose: This study aimed to investigate the ability of creatine-chemical exchange saturation transfer (Cr-CEST) technique assessed through 7-T MRI to evaluate cisplatin-induced testicular damage.
Methods: We used 8-10 weeks C57BL/6 mice (n = 10) that were divided into a control group (n = 5) and a cisplatin-treated group (n = 5). The cisplatin group received cisplatin at a dose of 15 mg/kg, via intraperitoneal injection, while the control group received saline. MR images of mouse testes were acquired under anesthesia 18 days after the injection using a horizontal 7-T scanner. The pulse sequence consisted of rapid acquisition with a relaxation enhancement (RARE) with magnetization transfer. The Z-spectra were collected using a 2000-ms saturation pulse at a B1 amplitude of 1.2 μT, with frequencies varying from -4.8 to +4.8 parts per million (ppm). Maps of magnetization transfer ratio with asymmetric analysis (MTRasym) were reconstructed at a Cr metabolite concentration of 1.8 ppm.
Results: The Cr-CEST effect was significantly reduced in the cisplatin-treated group compared to the control group (MTRasym of control mice vs. cisplatin-treated mice: 6.9 [6-7.5] vs. 5.2 [4-5.5], P = 0.008). Correlation analysis revealed a strong correlation between the Cr-CEST effect and the pathological score (ρ = 0.93, P < 0.001).
Conclusion: Cr-CEST MRI can be useful for the evaluation of cisplatin-induced testicular damage in mice.
Keywords: chemical exchange saturation transfer; cisplatin; creatine; testes.
Conflict of interest statement
The authors declare that they have no conflicts of interest.
Figures





Similar articles
-
Evaluating the Cisplatin Dose Dependence of Testicular Dysfunction Using Creatine Chemical Exchange Saturation Transfer Imaging.Diagnostics (Basel). 2022 Apr 21;12(5):1046. doi: 10.3390/diagnostics12051046. Diagnostics (Basel). 2022. PMID: 35626202 Free PMC article.
-
Systematic Evaluation of Amide Proton Chemical Exchange Saturation Transfer at 3 T: Effects of Protein Concentration, pH, and Acquisition Parameters.Invest Radiol. 2016 Oct;51(10):635-46. doi: 10.1097/RLI.0000000000000292. Invest Radiol. 2016. PMID: 27272542
-
Accurate Estimation of the Duration of Testicular Ischemia Using Creatine Chemical Exchange Saturation Transfer (CrCEST) Imaging.J Magn Reson Imaging. 2021 May;53(5):1559-1567. doi: 10.1002/jmri.27456. Epub 2020 Dec 17. J Magn Reson Imaging. 2021. PMID: 33336504
-
Chemical exchange saturation transfer imaging of creatine, phosphocreatine, and protein arginine residue in tissues.NMR Biomed. 2023 Jun;36(6):e4671. doi: 10.1002/nbm.4671. Epub 2022 Jan 3. NMR Biomed. 2023. PMID: 34978371 Free PMC article. Review.
-
Magnetization Transfer Contrast and Chemical Exchange Saturation Transfer MRI. Features and analysis of the field-dependent saturation spectrum.Neuroimage. 2018 Mar;168:222-241. doi: 10.1016/j.neuroimage.2017.04.045. Epub 2017 Apr 21. Neuroimage. 2018. PMID: 28435103 Free PMC article. Review.
Cited by
-
Intratesticular creatine maintains spermatogenesis by defining tight junctions.Sci Rep. 2024 Dec 28;14(1):30692. doi: 10.1038/s41598-024-77986-3. Sci Rep. 2024. PMID: 39730393 Free PMC article.
-
Evaluation of the efficacy of creatine chemical exchange saturation transfer imaging in assessing testicular maturity.Reprod Med Biol. 2023 Feb 23;22(1):e12507. doi: 10.1002/rmb2.12507. eCollection 2023 Jan-Dec. Reprod Med Biol. 2023. PMID: 36845001 Free PMC article.
-
Preclinical magnetic resonance imaging and spectroscopy in the fields of radiological technology, medical physics, and radiology.Radiol Phys Technol. 2024 Mar;17(1):47-59. doi: 10.1007/s12194-024-00785-y. Epub 2024 Feb 14. Radiol Phys Technol. 2024. PMID: 38351261 Free PMC article. Review.
References
-
- DeSantis CE, Lin CC, Mariotto AB, et al. Cancer treatment and survivorship statistics, 2014. CA Cancer J Clin 2014; 64:252–271. - PubMed
-
- Howell SJ, Shalet SM. Spermatogenesis after cancer treatment: damage and recovery. J Natl Cancer Inst Monogr 2005; 2005:12–17. - PubMed
-
- Schlegel PN, Sigman M, Collura B, et al. Diagnosis and treatment of infertility in men: AUA/ASRM guideline part I. Fertil Steril 2021; 115:54–61. - PubMed